Amble vs Nurx
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Amble
Best for mainstream telehealth GLP-1 accessStarting at $179/mo
Nurx
Best for mainstream telehealth GLP-1 accessStarting at $179/mo
Side-by-Side Comparison
| Feature | Amble | Nurx |
|---|---|---|
| Overall Score | 7.4/10 | 7.4/10 |
| Starting Price | $179/mo | $179/mo |
| Editorial Rating | 3.7 ★ /5 | 3.7 ★ /5 |
| Features | 3 features | 3 features |
| States Available | ✓50 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Amble
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Nurx
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Our Verdict
Both Amble and Nurx score equally well overall — the right choice depends on your priorities. Choose Amble if you want mainstream telehealth GLP-1 access, or Nurx if mainstream telehealth GLP-1 access matters most to you.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.